Vor Bio to Participate in the Goldman Sachs Healthcare Conference
June 05 2023 - 8:00AM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, will present and host in-person 1x1 investor meetings at
the Goldman Sachs 44th Annual Global Healthcare Conference.
Goldman Sachs 44th Annual Global Healthcare
ConferenceFireside Chat: Monday, June 12, 2023 at 8:00am
PTLocation: Waldorf Astoria Monarch Beach Resort & Club, Dana
Point, CA
A live webcast and archived replay of the fireside chat will be
available on the investors section of our website, linked here:
https://ir.vorbio.com/events-presentations/
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart
From Apr 2024 to May 2024
Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart
From May 2023 to May 2024